Regulatory Frameworks and Compliance
What this domain tests
This domain tests the market-conduct rulebook: registration, inside-information handling, transaction and fundamental-data reporting, record keeping, and the boundary between legitimate commercial behaviour and abuse.
Core rules and concepts
- Inside information is precise, non-public information that could significantly affect wholesale energy prices. It must be disclosed effectively and in a timely manner, commonly through an urgent market message (UMM) or a transparency platform.
- Prohibition: no trading or recommending trades on inside information, and no disclosing it outside the normal exercise of employment or profession.
- Market abuse includes manipulative transactions, false or misleading orders, and attempting to manipulate the market; intent and effect both matter.
- Reporting: reportable contracts and orders must be reported to the designated authority or registered reporting mechanism, with accurate counterparty, product, price, quantity, and timing fields.
- Record keeping: communications and transaction records must be retained for the prescribed period and be retrievable on request.
- Jurisdictional layering: REMIT-style conduct rules, EMIR-style derivative reporting, and MiFID-style trading rules can apply to the same trade; compliance with one does not satisfy the others.
Worked example
An operator learns at 09:00 that a 400 MW unit will be unavailable for three days. The information is precise and not public. Before 10:00, a trader sells baseload power for the operator’s book. The compliance issue is not whether the trader “felt” the information was material; the operator must assess whether disclosure can be delayed for legitimate reasons, disclose via the required channel, and prevent trading ahead of disclosure. A sale before effective disclosure is a strong insider-trading indicator. The firm should preserve the outage log, emails, order timestamps, and disclosure record.
Traps that cost marks
Confusing REMIT conduct rules with EMIR reporting; assuming exchange rules cover all OTC activity; delaying disclosure for reputational convenience rather than a permitted legitimate reason; and treating “no trade” as sufficient when the firm also recommended or disclosed the information.